Hoth Therapeutics, Inc. — Director's Dealing 2022

Sep 20, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Hoth Therapeutics, Inc. (HOTH)
CIK: 0001711786
Period of Report: 2022-09-19

Reporting Person: Knie Robb (Director, CEO and President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-09-19	Common Stock	P	10000	$0.39	Acquired	828259	Direct